Net profit of Concord Biotech declined 33.59% to Rs 63.58 crore in the quarter ended September 2025 as against Rs 95.74 crore during the previous quarter ended September 2024. Sales declined 20.35% to Rs 247.06 crore in the quarter ended September 2025 as against Rs 310.18 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales247.06310.18 -20 OPM %35.8243.11 - PBDT104.08143.65 -28 PBT85.68130.34 -34 NP63.5895.74 -34 Powered by Capital Market - Live News

Net profit of Concord Biotech declined 36.27% to Rs 62.90 crore in the quarter ended September 2025 as against Rs 98.70 crore during the previous quarter ended September 2024. Sales declined 20.35% to Rs 247.06 crore in the quarter ended September 2025 as against Rs 310.18 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales247.06310.18 -20 OPM %36.6544.06 - PBDT103.92146.60 -29 PBT85.53133.29 -36 NP62.9098.70 -36 Powered by Capital Market - Live News

Concord Biotech will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News

Concord Biotech announced that the European Union Good Manufacturing Practice (EU-GMP) authorities have conducted their first inspection of its Active Pharmaceutical Ingredients (API) manufacturing facility located at Limbassi. The inspection was carried out from 18 August 2025 to 21 August 2025. This milestone marks a significant achievement for Concord, as a successful EU-GMP inspection not only validates our commitment to global quality standards but also paves the way for expanding our footprint into new international markets. The approval will enable Concord to explore commercial opportunities across various EU territories and other regulated geographies, strengthening our global presence and growth trajectory, said the company. Powered by Capital Market - Live News

Concord Biotech announced that the Annual General Meeting(AGM) of the company will be held on 9 September 2025.Powered by Capital Market - Live News